Intended for US audiences only

OPTUNE LUA STUDY RESULTS

In a clinical trial, Optune Lua was studied in 291 people with metastatic NSCLC.

Half used Optune Lua together with a class of immunotherapy known as PD-1/PD-L1 inhibitors or a type of chemotherapy called docetaxel, while the other half did not use Optune Lua.

The results:

People lived longer

People using Optune Lua with cancer drugs* lived for over 13 months, compared to nearly 10 months for people using cancer drugs* alone.

*Cancer drugs=PD-1/PD-L1 inhibitors or docetaxel.

About half of people using Optune Lua with cancer drugs* were still living at 1 year compared to 42% of people using cancer drugs* alone.

In a clinical study, using Optune Lua with specific cancer drugs* helped people live longer

Using Optune Lua with PD-1/PD-L1 inhibitors helped people live about 8 months longer than those who used PD-1/PD-L1 inhibitors alone.



 

61% of people using Optune Lua with PD-1/PD-L1 inhibitors were still living at 1 year compared with 46% of people using PD-1/PD-L1 inhibitors alone. This difference was statistically significant.

Using Optune Lua with docetaxel helped people live about 2 months longer than those using doxetacel alone.



 

46% of people using Optune Lua with docetaxel were still living at 1 year compared to 39% of people using docetaxel alone. The difference was not statistically significant.

People maintained their quality of life, including mental, emotional, and physical health, over 12 months while using Optune Lua with cancer drugs* or cancer drugs* alone.

*Cancer drugs=PD-1/PD-L1 inhibitors or docetaxel.

 

Based on the European Organisation for Research and Treatment of Cancer core quality of life questionnaire. Data was collected for 54 weeks.

Learn about possible side effects with Optune Lua 

Find out more

Get 24/7 support during treatment

Discover MyNovocure®

Important Safety Information and Indication

Who should not use Optune Lua?

Optune Lua for mNSCLC is not for everyone. Talk to your doctor if you have:

  • An electrical implant. Use of Optune Lua together with electrical implants has not been tested and may cause the implanted device not to work properly
  • A known sensitivity to gels like the gel used on electrocardiogram (ECG) stickers or transcutaneous electrical nerve stimulation (TENS) electrodes. In this case, skin contact with the gel used with Optune Lua may commonly cause increased redness and itching, and rarely may even lead to severe allergies such as a fall in blood pressure and difficulty breathing

Do not use Optune Lua if you are pregnant or are planning to become pregnant. It is not known if Optune Lua is safe or effective during pregnancy.

 

What should I know before using Optune Lua?

Optune Lua should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune Lua.

  • Do not use any parts that did not come with Optune Lua Treatment Kit sent to you by Novocure or given to you by your doctor
  • Do not get the device or transducer arrays wet
  • Please be aware that Optune Lua has a cord that plugs into an electrical socket. Be careful of tripping when it's connected 
  • If you have an underlying serious skin condition where the transducer arrays are placed, discuss with your doctor whether this may prevent or temporarily interfere with Optune Lua treatment

 

What are the possible side effects of Optune Lua?

The most common side effects of Optune Lua when used together with certain immunotherapy and chemotherapy drugs were dermatitis, pain in the muscles, bones, or joints, fatigue, anemia, alopecia (hair loss), dyspnea, nausea, cough, diarrhea, anorexia, pruritus (itching), leukopenia, pneumonia, respiratory tract infection, localized edema (swelling), rash, pain, constipation, skin ulcers, hypokalemia (low potassium levels), hypoalbuminemia (low albumin levels), hyponatremia (low sodium levels), and dysphagia (difficulty swallowing).

 

Other potential adverse effects associated with the use of Optune Lua include treatment related skin irritation, allergic reaction to the adhesive or to the gel, overheating of the array leading to pain and/or local skin burns, infections at site where the arrays make contact with the skin, local warmth and tingling sensation beneath the arrays, medical device site reaction, muscle twitching, and skin breakdown/skin ulcer. Talk to your doctor if you have any of these side effects or questions.

 

What is Optune Lua® approved to treat?

Optune Lua is a wearable, portable, FDA-approved device used together with PD-1/PD-L1 inhibitors (immunotherapy) or docetaxel. It is indicated for adult patients with metastatic non-small cell lung cancer (mNSCLC) who have progressed on or after a platinum-based regimen.

 

Please see Patient Information and Operation Manual (PIOM) for Optune Lua.

 

Important Safety Information and Indication

Who should not use Optune Lua?

Optune Lua for mNSCLC is not for everyone. Talk to your doctor if you have:

  • An electrical implant. Use of Optune Lua together with electrical implants has not been tested and may cause the implanted device not to work properly
  • A known sensitivity to gels like the gel used on electrocardiogram (ECG) stickers or transcutaneous electrical nerve stimulation (TENS) electrodes. In this case, skin contact with the gel used with Optune Lua may commonly cause increased redness and itching, and rarely may even lead to severe allergies such as a fall in blood pressure and difficulty breathing

Do not use Optune Lua if you are pregnant or are planning to become pregnant. It is not known if Optune Lua is safe or effective during pregnancy.

 

What should I know before using Optune Lua?

Optune Lua should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune Lua.

  • Do not use any parts that did not come with Optune Lua Treatment Kit sent to you by Novocure or given to you by your doctor
  • Do not get the device or transducer arrays wet
  • Please be aware that Optune Lua has a cord that plugs into an electrical socket. Be careful of tripping when it's connected 
  • If you have an underlying serious skin condition where the transducer arrays are placed, discuss with your doctor whether this may prevent or temporarily interfere with Optune Lua treatment

 

What are the possible side effects of Optune Lua?

The most common side effects of Optune Lua when used together with certain immunotherapy and chemotherapy drugs were dermatitis, pain in the muscles, bones, or joints, fatigue, anemia, alopecia (hair loss), dyspnea, nausea, cough, diarrhea, anorexia, pruritus (itching), leukopenia, pneumonia, respiratory tract infection, localized edema (swelling), rash, pain, constipation, skin ulcers, hypokalemia (low potassium levels), hypoalbuminemia (low albumin levels), hyponatremia (low sodium levels), and dysphagia (difficulty swallowing).

 

Other potential adverse effects associated with the use of Optune Lua include treatment related skin irritation, allergic reaction to the adhesive or to the gel, overheating of the array leading to pain and/or local skin burns, infections at site where the arrays make contact with the skin, local warmth and tingling sensation beneath the arrays, medical device site reaction, muscle twitching, and skin breakdown/skin ulcer. Talk to your doctor if you have any of these side effects or questions.

 

What is Optune Lua® approved to treat?

Optune Lua is a wearable, portable, FDA-approved device used together with PD-1/PD-L1 inhibitors (immunotherapy) or docetaxel. It is indicated for adult patients with metastatic non-small cell lung cancer (mNSCLC) who have progressed on or after a platinum-based regimen.

 

Please see Patient Information and Operation Manual (PIOM) for Optune Lua.

 

Novocure Websites

This website is intended for people seeking information on Optune Lua.

 

 

 

 

 




©2024 Novocure GmbH. All Rights Reserved.

MyNovocure, Novocure, and Optune Lua are registered trademarks of Novocure GmbH.

US-OPL-00036 v1.0 November 2024